Clinical trial
HCV Treatment of IDUs After Buprenorphine Stabilization
NCT00249574 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HCV Treatment of IDUs After Buprenorphine Stabilization
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- June 30, 2006
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.